Table 4 Multivariate analysis to predict Multidrug-resistant pathogens
From: Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
Multidrug-Resistant Microorganisms | |||
|---|---|---|---|
ORa | 95% CIb | p | |
Age | 1.03 | 0.97-1.09 | 0.393 |
Male | 0.77 | 0.25–2.41 | 0.656 |
Arterial hypertension | 0.83 | 0.27–2.62 | 0.756 |
Congestive heart failure | 1.60 | 0.40–6.45 | 0.511 |
COPD | 1.51 | 0.45–5.03 | 0.500 |
Renal disease | 7.60 | 1.92–30.09 | 0.004 |
Age-adjusted Charlson >5 | 0.64 | 0.19–2.16 | 0.469 |
Chronic Pseudomonas aeruginosa infection | 0.41 | 0.11–1.55 | 0.189 |
Prior multidrug-resistant microorganism isolation | 5.58 | 2.02–15.46 | 0.001 |
Inhaled/Nebulized antibiotic | 1.93 | 0.57–6.47 | 0.288 |
Chronic oxygen therapy | 1.90 | 0.57–6.32 | 0.297 |
Hospitalization last year | 3.88 | 1.37–11.02 | 0.011 |
Severe FACED | 0.72 | 0.22–2.29 | 0.573 |
Severe BSI | 1.58 | 0.42–5.95 | 0.501 |